Unknown

Dataset Information

0

DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development.


ABSTRACT: Recurrence of estrogen receptor (ER)-positive breast tumors despite curative-intent adjuvant therapy is thought to be due to enrichment of tumor initiating cells (TIC) during endocrine therapy (ET). Recently, it was identified that by antagonizing the ER, ET promotes rapid degradation of the death-associated factor 6 (DAXX) protein, which is necessary and sufficient to potently inhibit TICs. Thus, the goal of the current study was to identify a DAXX-inducing agent to inhibit TICs and prevent proliferation of the tumor. Phytoestrogens (naringenin, resveratrol, genistein, apigenin, and quercetin) were screened for DAXX protein expression, anti-TIC and anti-proliferative efficacy in vitro and in vivo. Specific DAXX-inducing phytoestrogens were tested to assess selectivity towards ER? and/or ER?. Results showed that phytoestrogens tested induced DAXX protein expression and inhibited survival of TICs from ER+ MCF-7 and T47D cells. Only naringenin, resveratrol, and quercetin did not stimulate total cell proliferation. Naringenin, resveratrol, but not quercetin inhibited survival of TICs in vitro and in vivo in a DAXX-dependent manner. Naringenin-induced DAXX protein expression and inhibition of TICs seemed to be more selective towards ER? while resveratrol was more selective through ER?. Naringenin or resveratrol inhibited the rate of tumor initiation and rate of tumor growth in a DAXX-dependent manner. These results suggest that a therapeutic approach using a phytoestrogen to induce DAXX protein expression could potently inhibit TICs within a tumor to delay or prevent tumor initiation. Therefore, a DAXX-promoting phytoestrogen should be explored for prevention of tumor progression in advanced disease and relapse in the adjuvant setting.

SUBMITTER: Peiffer DS 

PROVIDER: S-EPMC7429502 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6774875 | BioStudies
2015-01-01 | S-EPMC4610175 | BioStudies
1000-01-01 | S-EPMC5598505 | BioStudies
2016-01-01 | S-EPMC4860103 | BioStudies
2014-01-01 | S-EPMC4195806 | BioStudies
2015-01-01 | S-EPMC4549392 | BioStudies
2019-01-01 | S-EPMC6768326 | BioStudies
2013-01-01 | S-EPMC3534701 | BioStudies
1000-01-01 | S-EPMC5361678 | BioStudies
2013-01-01 | S-EPMC3933790 | BioStudies